Craig is recognised for providing pragmatic, commercially focused advice to clients in the biotechnological, pharmaceutical, chemical and MedTech sectors. As well as patent drafting and prosecution, Craig advises on the development of company-wide IP strategies, funding/acquisition due-diligence, and aggressive/defensive strategies in relation to third-party IP.
Having worked closely with multi-national corporations, Craig understands the challenges associated with efficiently prosecuting large multi-national patent portfolios, whilst keeping them relevant to the business. He values this experience as it helps him to provide expert guidance to SMEs as they grow or prepare for acquisition.
Whilst part of Craig’s focus is ensuring that technical aspects of each invention is accurately captured in a patent, he understands that the value of IP can only be fully realised after understanding the commercial goals of a business, and how IP can best be exploited to help underpin those goals. It is therefore important for him to understand more generally his client’s business; enabling him to provide them with a more broad-ranging, effective and valuable set of solutions. Industry sectors for which Craig has considerable knowledge of include those concerned with the microbiome, food, formulations, anti-infectives, diagnostics and MedTech.
Craig has a proven track record of providing successful outcomes for clients, both in a wide-range of legal proceedings (including opposition, entitlement, and USPTO interviews) and in successful IP-license/assignment deals involving patents that he both drafted and prosecuted to grant. He has co-written an amicus curiae (filed with the US Supreme Court for Sequenom v Ariosa), and has assisted many clients to successfully obtain investment, including listing on AIM.
Physiology and Pharmacology
Management of Intellectual Property
“Craig Thomson, who is well versed in all things biotechnological and pharmaceutical, particularly therapeutic and diagnostic inventions. He has a “phenomenal ability to quickly grasp the key concepts in an invention and tease out the most inventive aspects so as to file the strongest possible patents. He is always on hand to guide patent strategy and has incredible patience when explaining the intricacies of the prosecution process. He is also ridiculously good fun to work with!” “He takes a practical, business-oriented approach, focusing on what will drive value in the European market in a way that enables informed decision making. In view of technological convergence, his technical versatility is invaluable.””
“Taking the reins on this initiative is Craig Thomson, an experienced handler of biotech, pharmaceutical, chemical and medical innovations. Thomson is a seasoned prosecutor and serves up trenchant advice on IP strategy in connection with technology-driven deals and enforcement issues; the broad ambit of his practice has helped him develop a refined commercial sense.”
June 29th 2023
October 22nd 2022
October 26th 2021
October 21st 2021
October 4th 2021
March 24th 2021
March 3rd 2021
January 27th 2021
January 14th 2021
October 15th 2020
October 15th 2020
September 8th 2020
September 1st 2020
July 8th 2020
April 24th 2020
September 26th 2019
June 3rd 2019
Craig provides the annual lecture, “Capturing, Protecting and Exploiting Intellectual Property in Business”, on the Masters Course for “Management of Innovation and Creativity” at Glasgow Caledonian University.
As IP lead, Craig is part of the Microbiome Innovation Network, part of the KTN, whos aims are to accelerate the commercialisation of microbiome-based products and services in the UK and create a vibrant community by connecting industry and academia. Craig also wrote the IP section for the Networks Roadmap document for the industry (https://ktn-uk.org/agrifood/microbiome/).
A patent is a legal right that enables the patent holder to prevent others from making and using their invention in the country where the patent is granted. To many …Read article
Order of the classifications listed on the front of a patent and why it matters? On 1 June 2023, ASTELLAS INSTITUTE FOR REGENERATIVE MEDICINE lodged a statement of revocation of …Read article
HGF is pleased to invite you to our upcoming German-language webinar in cooperation with the BVIZ on “In- and Out-licensing of Technologies” on 16th of November 2023. The webinar will …Event details
The advent of commercial launch capabilities has opened up space as a unique frontier for innovation. However, in space, any acts of patent infringement almost always go unseen. Thus, it’s …Read article
Any communications sent from the EPO on or after 1 November 2023 will no longer have the “ten day rule” applied to them. This means that communications are deemed to …Read article
HGF is pleased to invite you to our upcoming German-language seminar on “In- and Out-licensing of Technologies” in Salzburg and Dresden. The seminar will offer you the opportunity to gain …Event details
Bioforward, OBN’s ‘Roadmap for Growth’ Life Sciences event is set to take place at The King’s Centre in Oxford on Tuesday 26th September 2023. This event is designed to provide the support, skills, know-how …Event details
The integration of artificial intelligence (AI) into healthcare has ushered in a new era of personalised medicine, promising more effective and tailored treatments for patients. Traditional medical approaches often adopt …Read article
If you would like to discuss how HGF could help you, contact one of our IP specialists.